津药药业 - Financials

津药药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006	FY 2005Dec 31, 2005
+Revenue	3.2B	3.8B	3.7B	3.7B	3.1B	3.3B	2.4B	2.0B	1.7B	1.4B	1.4B	1.5B	1.8B	1.4B	1.1B	887.0M	877.0M	699.0M	607.0M	661.0M
Revenue Growth %	-15.0%	2.5%	-1.6%	20.3%	-6.3%	37.1%	23.1%	16.8%	20.2%	1.2%	-6.2%	-16.4%	24.9%	25.7%	27.2%	1.1%	25.5%	15.2%	-8.2%	--
Total Revenue	3.2B	3.8B	3.7B	3.7B	3.1B	3.3B	2.4B	2.0B	1.7B	1.4B	1.4B	1.5B	1.8B	1.4B	1.1B	887.0M	877.0M	699.0M	607.0M	661.0M
Cost Of Revenue	1.8B	2.0B	1.9B	2.0B	1.7B	1.7B	1.2B	1.2B	1.2B	1.2B	1.2B	1.3B	1.5B	1.2B	867.0M	659.0M	677.0M	542.0M	432.0M	478.0M
+Gross Profit	1.5B	1.8B	1.8B	1.8B	1.4B	1.6B	1.2B	733.0M	496.0M	228.0M	214.0M	204.0M	300.0M	263.0M	261.0M	228.0M	200.0M	157.0M	175.0M	183.0M
Gross Margin %	45.4%	46.4%	49.1%	47.6%	46.0%	49.4%	50.8%	37.2%	29.4%	16.2%	15.4%	13.8%	16.9%	18.5%	23.1%	25.7%	22.8%	22.5%	28.8%	27.7%
Total Operating Cost	3.0B	3.6B	3.6B	3.6B	3.0B	3.0B	2.2B	1.8B	1.5B	1.3B	1.3B	1.4B	1.7B	1.3B	1.0B	819.0M	822.0M	667.0M	560.0M	567.0M
Selling Expenses	570.0M	1.1B	1.1B	1.2B	842.0M	871.0M	650.0M	302.0M	151.0M	24.0M	24.8M	26.7M	23.1M	21.3M	24.0M	19.3M	17.1M	14.1M	10.4M	9.4M
Admin Expenses	361.0M	286.0M	246.0M	231.0M	212.0M	222.0M	154.0M	101.0M	179.0M	121.0M	98.7M	99.7M	117.0M	111.0M	106.0M	92.8M	85.5M	62.6M	70.6M	52.2M
Rd Expenses	204.0M	161.0M	143.0M	133.0M	138.0M	144.0M	103.0M	90.3M	--	--	--	--	--	--	--	--	--	--	--	--
Finance Expenses	7.9M	17.2M	29.2M	45.2M	44.4M	37.6M	22.2M	7.3M	-6.0M	-5.9M	13.3M	25.4M	28.7M	31.1M	25.9M	29.2M	40.5M	41.7M	40.0M	25.5M
+Operating Income	226.0M	169.0M	70.2M	146.0M	132.0M	281.0M	222.0M	188.0M	151.0M	83.9M	69.8M	44.7M	121.0M	100.0M	101.0M	73.0M	55.2M	31.1M	46.6M	95.2M
Operating Margin %	7.0%	4.5%	1.9%	3.9%	4.2%	8.4%	9.1%	9.5%	8.9%	6.0%	5.0%	3.0%	6.8%	7.1%	9.0%	8.2%	6.3%	4.4%	7.7%	14.4%
Non Operating Income	1.9M	1.3M	1.3M	4.5M	24.7M	10.6M	1.1M	1.9M	4.2M	3.3M	29.9M	12.4M	3.3M	543.0M	4.2M	8.0M	2.7M	1.5M	6.3M	162,300
Non Operating Expenses	893,200	2.5M	59.0M	1.3M	44.8M	1.3M	3.4M	912,300	147,000	173,000	205,500	9,900	37,700	533.0M	230,700	5.5M	226,400	299,300	705,500	440,300
Investment Income	-9.1M	-1.1M	-22.4M	5.0M	-1.2M	-4.8M	9.3M	12.1M	3,128	4.0M	3.7M	450,800	3.9M	5.4M	5.9M	5.0M	620,000	-861,400	-231,100	-35,800
Asset Disposal Income	-33,500	651,900	-938,700	-19,800	-181,000	45,200	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Asset Impairment Loss	72.2M	57.2M	124.0M	53.4M	45.1M	52.5M	64.6M	34.2M	2.2M	2.5M	686,100	1.1M	6.9M	-2.2M	5.4M	12.7M	-1.2M	2.2M	4.4M	--
Other Income	28.7M	34.4M	14.7M	12.0M	13.7M	8.8M	5.2M	3.3M	--	--	--	--	--	--	--	--	--	--	--	--
Income Before Tax	227.0M	168.0M	12.5M	149.0M	112.0M	290.0M	220.0M	189.0M	155.0M	87.0M	99.5M	57.0M	124.0M	110.0M	105.0M	75.5M	57.7M	32.3M	52.2M	95.0M
Income Tax	18.3M	5.6M	-5.9M	40.4M	31.8M	76.3M	33.6M	26.7M	18.2M	8.2M	12.8M	5.0M	15.0M	15.1M	12.3M	8.4M	6.0M	4.2M	6.4M	13.5M
+Net Income	208.0M	163.0M	18.4M	109.0M	80.6M	214.0M	186.0M	162.0M	136.0M	78.8M	86.7M	52.0M	109.0M	95.1M	92.8M	67.1M	51.7M	28.0M	45.8M	81.5M
Net Margin %	6.5%	4.3%	0.5%	2.9%	2.6%	6.4%	7.7%	8.2%	8.1%	5.6%	6.2%	3.5%	6.2%	6.7%	8.2%	7.6%	5.9%	4.0%	7.6%	12.3%
Net Income Attributable	133.0M	117.0M	35.4M	48.7M	34.0M	162.0M	145.0M	130.0M	97.7M	78.7M	86.6M	51.9M	109.0M	93.2M	90.8M	65.4M	50.2M	26.1M	45.0M	80.8M
Minority Interest	74.8M	45.6M	-17.0M	60.0M	46.6M	51.9M	41.1M	32.6M	38.7M	83,700	140,000	72,900	71,600	1.9M	2.0M	1.7M	1.5M	1.9M	823,300	698,000
Eps Basic	0.12	0.11	0.03	0.05	0.03	0.15	0.13	0.12	0.09	0.08	0.09	0.06	0.13	0.17	0.17	0.12	0.09	0.05	0.10	0.32
Eps Diluted	0.12	0.11	0.03	0.05	0.03	0.15	0.13	0.12	0.09	0.08	0.09	0.06	0.13	0.17	0.17	0.12	0.09	0.05	0.10	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006	FY 2005Dec 31, 2005
Cash And Equivalents	638.0M	719.0M	648.0M	232.0M	244.0M	252.0M	345.0M	480.0M	641.0M	453.0M	536.0M	566.0M	232.0M	242.0M	135.0M	178.0M	163.0M	259.0M	545.0M	207.0M
Trading Financial Assets	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Accounts Receivable	291.0M	430.0M	342.0M	501.0M	379.0M	274.0M	198.0M	235.0M	241.0M	142.0M	190.0M	192.0M	158.0M	93.8M	71.8M	97.4M	89.9M	113.0M	232.0M	222.0M
Notes Receivable	1.1M	--	1.2M	1.9M	2.8M	--	119.0M	129.0M	89.5M	54.8M	78.9M	39.5M	53.8M	25.9M	28.9M	43.6M	44.4M	28.0M	17.5M	10.6M
Notes And Accounts Receivable	292.0M	430.0M	343.0M	503.0M	381.0M	274.0M	317.0M	365.0M	331.0M	197.0M	269.0M	231.0M	212.0M	120.0M	101.0M	141.0M	134.0M	141.0M	249.0M	233.0M
Prepayments	22.5M	48.9M	15.4M	42.0M	15.6M	19.0M	9.8M	8.2M	38.0M	15.7M	10.2M	44.8M	62.9M	107.0M	169.0M	109.0M	108.0M	54.7M	38.7M	19.1M
Inventory	652.0M	726.0M	1.2B	976.0M	1.1B	1.3B	1.5B	972.0M	749.0M	670.0M	528.0M	638.0M	644.0M	607.0M	706.0M	510.0M	665.0M	605.0M	625.0M	576.0M
Total Current Assets	1.8B	2.1B	2.4B	1.9B	1.9B	2.0B	2.2B	1.9B	1.8B	1.5B	1.4B	1.5B	1.2B	1.1B	1.1B	942.0M	1.1B	1.1B	1.5B	1.1B
Long Term Equity Investment	13.6M	22.3M	22.0M	25.0M	26.3M	34.0M	31.6M	30.7M	17.5M	21.5M	17.3M	9.2M	98.6M	103.0M	97.3M	95.0M	93.8M	97.9M	94.4M	82.2M
Fixed Assets	--	3.0B	3.0B	2.8B	2.7B	2.7B	2.3B	1.7B	1.7B	1.3B	1.3B	1.3B	1.3B	978.0M	661.0M	596.0M	640.0M	648.0M	488.0M	544.0M
Fixed Assets Total	2.8B	3.0B	3.0B	2.8B	2.7B	2.7B	2.3B	1.7B	1.7B	1.3B	1.3B	1.3B	1.3B	978.0M	661.0M	596.0M	782.0M	648.0M	488.0M	544.0M
Construction In Progress	--	30.2M	118.0M	508.0M	396.0M	226.0M	157.0M	288.0M	211.0M	16.4M	77.8M	68.5M	93.3M	120.0M	380.0M	612.0M	443.0M	327.0M	275.0M	208.0M
Construction In Progress Total	44.5M	34.4M	127.0M	544.0M	495.0M	259.0M	191.0M	333.0M	244.0M	22.4M	84.8M	75.6M	111.0M	138.0M	392.0M	684.0M	474.0M	331.0M	284.0M	275.0M
Intangible Assets	350.0M	304.0M	255.0M	192.0M	120.0M	103.0M	65.7M	64.0M	53.1M	36.8M	30.5M	26.1M	19.2M	15.6M	23.8M	111.0M	116.0M	117.0M	77.7M	22.9M
Long Term Deferred Expenses	--	--	1.8M	1.4M	1.9M	2.4M	2.9M	3.4M	4.0M	--	--	--	--	--	--	--	209,200	1.0M	1.3M	1.3M
Total Non Current Assets	3.9B	4.0B	4.3B	4.5B	4.3B	3.7B	3.0B	2.4B	2.3B	1.5B	1.5B	1.6B	1.6B	1.3B	1.8B	1.7B	1.5B	1.2B	957.0M	926.0M
Total Assets	5.7B	6.1B	6.7B	6.3B	6.2B	5.7B	5.2B	4.3B	4.1B	3.0B	2.9B	3.1B	2.8B	2.4B	2.9B	2.6B	2.6B	2.3B	2.4B	2.0B
Short Term Borrowings	109.0M	270.0M	648.0M	589.0M	831.0M	555.0M	402.0M	--	--	13.6M	3.2M	19.2M	46.3M	75.9M	244.0M	409.0M	824.0M	738.0M	816.0M	461.0M
Accounts Payable	529.0M	681.0M	627.0M	505.0M	471.0M	424.0M	606.0M	188.0M	178.0M	150.0M	85.2M	123.0M	142.0M	179.0M	306.0M	154.0M	102.0M	89.1M	75.8M	134.0M
Advance Receipts	7,100	475,900	1.4M	18.0M	25.1M	67.9M	60.3M	47.9M	26.6M	5.1M	1.7M	107.0M	9.7M	21.9M	54.7M	29.7M	10.3M	16.7M	18.1M	4.6M
Contract Liabilities	79.7M	137.0M	134.0M	68.4M	25.9M	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	1.2B	1.9B	2.3B	2.0B	1.8B	1.8B	1.5B	1.1B	280.0M	574.0M	105.0M	764.0M	215.0M	713.0M	687.0M	817.0M	1.1B	855.0M	961.0M	932.0M
Long Term Borrowings	425.0M	277.0M	459.0M	367.0M	402.0M	--	385.0M	--	385.0M	--	385.0M	--	500.0M	--	600.0M	250.0M	--	--	--	--
Total Non Current Liabilities	597.0M	449.0M	617.0M	505.0M	598.0M	130.0M	424.0M	24.4M	408.0M	10.0M	396.0M	22.1M	531.0M	17.0M	601.0M	251.0M	800,000	44,900	391.0M	1.0M
Total Liabilities	1.8B	2.4B	2.9B	2.5B	2.4B	1.9B	1.9B	1.2B	688.0M	584.0M	501.0M	786.0M	745.0M	730.0M	1.3B	1.1B	1.1B	855.0M	1.4B	933.0M
Paid In Capital	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	961.0M	961.0M	961.0M	961.0M	543.0M	543.0M	543.0M	543.0M	543.0M	543.0M	453.0M	252.0M
Capital Reserve	320.0M	322.0M	327.0M	335.0M	335.0M	470.0M	530.0M	515.0M	845.0M	609.0M	609.0M	609.0M	803.0M	509.0M	509.0M	509.0M	509.0M	509.0M	212.0M	417.0M
Surplus Reserve	248.0M	237.0M	229.0M	216.0M	216.0M	216.0M	199.0M	188.0M	171.0M	150.0M	143.0M	136.0M	131.0M	122.0M	112.0M	103.0M	97.6M	93.9M	91.6M	87.2M
Retained Earnings	1.3B	1.3B	1.2B	1.2B	1.1B	1.1B	1.0B	926.0M	792.0M	711.0M	667.0M	604.0M	568.0M	496.0M	429.0M	364.0M	320.0M	285.0M	269.0M	241.0M
Minority Equity	829.0M	800.0M	781.0M	824.0M	781.0M	756.0M	447.0M	410.0M	656.0M	20.8M	20.7M	20.6M	20.5M	20.4M	40.3M	38.4M	35.3M	31.1M	49.0M	48.2M
Equity Attributable	3.1B	3.0B	3.0B	3.0B	3.0B	3.0B	2.8B	2.7B	2.8B	2.4B	2.4B	2.3B	2.0B	1.7B	1.6B	1.5B	1.5B	1.4B	1.0B	996.0M
Total Equity	3.9B	3.8B	3.8B	3.8B	3.8B	3.8B	3.3B	3.1B	3.4B	2.4B	2.4B	2.3B	2.1B	1.7B	1.6B	1.6B	1.5B	1.5B	1.1B	1.0B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006	FY 2005Dec 31, 2005
Cash From Sales	3.1B	3.4B	3.5B	3.2B	2.7B	2.5B	1.9B	1.3B	1.2B	922.0M	915.0M	1.2B	1.3B	1.2B	839.0M	1.1B	1.0B	683.0M	490.0M	600.0M
Tax Refunds Received	131.0M	114.0M	113.0M	91.1M	104.0M	108.0M	56.2M	60.7M	44.8M	60.6M	45.2M	55.8M	52.6M	47.2M	44.5M	53.8M	21.1M	32.9M	30.9M	37.4M
Total Operating Cash Inflow	3.3B	3.6B	3.7B	3.4B	2.8B	2.7B	2.0B	1.4B	1.3B	995.0M	978.0M	1.2B	1.3B	1.3B	895.0M	1.2B	1.0B	725.0M	537.0M	642.0M
Cash Paid For Goods	1.7B	1.9B	2.2B	2.2B	1.7B	1.4B	1.1B	777.0M	641.0M	568.0M	478.0M	884.0M	1.0B	917.0M	533.0M	496.0M	606.0M	383.0M	327.0M	612.0M
Cash Paid To Employees	532.0M	427.0M	405.0M	385.0M	399.0M	438.0M	380.0M	310.0M	297.0M	175.0M	159.0M	150.0M	139.0M	130.0M	117.0M	101.0M	92.2M	80.5M	76.0M	67.6M
Taxes Paid	270.0M	309.0M	280.0M	260.0M	235.0M	342.0M	214.0M	169.0M	149.0M	75.7M	114.0M	67.6M	106.0M	68.1M	67.0M	80.7M	42.9M	51.0M	49.9M	40.0M
Total Operating Cash Outflow	2.7B	2.9B	3.0B	3.1B	2.5B	2.4B	1.8B	1.4B	1.3B	866.0M	799.0M	1.2B	1.3B	1.2B	778.0M	724.0M	816.0M	562.0M	486.0M	750.0M
Operating Cash Flow	569.0M	783.0M	654.0M	317.0M	347.0M	320.0M	192.0M	-8.1M	56.9M	130.0M	179.0M	84.6M	15.0M	78.5M	117.0M	435.0M	219.0M	162.0M	50.7M	-109.0M
Total Investing Cash Inflow	2.0M	1.0M	4.1M	4.1M	14.4M	964,200	8.7M	16.1M	154.0M	4.2M	-5.5M	101.0M	28.2M	575.0M	3.5M	3.3M	668,800	1.4M	236,300	1.6M
Total Investing Cash Outflow	78.1M	133.0M	202.0M	381.0M	599.0M	295.0M	655.0M	121.0M	79.7M	195.0M	27.9M	310.0M	75.6M	67.8M	148.0M	202.0M	362.0M	314.0M	88.4M	156.0M
Investing Cash Flow	-76.2M	-132.0M	-198.0M	-377.0M	-584.0M	-294.0M	-646.0M	-105.0M	74.1M	-191.0M	-33.4M	-209.0M	-47.4M	507.0M	-144.0M	-199.0M	-362.0M	-313.0M	-88.2M	-155.0M
Cash From Borrowings	780.0M	580.0M	1.1B	1.5B	2.0B	646.0M	787.0M	784,500	385.0M	80.9M	822.0M	325.0M	1.0B	766.0M	1.8B	1.5B	1.6B	1.3B	1.4B	1.1B
Dividends And Interest Paid	164.0M	67.0M	79.1M	73.9M	102.0M	138.0M	72.7M	30.5M	41.9M	43.0M	42.7M	38.2M	47.2M	63.4M	59.6M	58.7M	59.3M	50.0M	54.0M	49.9M
Debt Repayments	1.2B	996.0M	1.2B	1.2B	1.9B	578.0M	414.0M	784,500	429.0M	70.4M	953.0M	352.0M	973.0M	1.2B	1.7B	1.6B	1.6B	1.3B	1.4B	772.0M
Total Financing Cash Inflow	780.0M	580.0M	1.3B	1.7B	2.3B	714.0M	857.0M	784,500	407.0M	80.9M	822.0M	862.0M	1.0B	766.0M	1.8B	1.5B	1.6B	1.3B	1.8B	1.1B
Total Financing Cash Outflow	1.4B	1.1B	1.3B	1.6B	2.1B	856.0M	545.0M	36.2M	495.0M	113.0M	996.0M	398.0M	1.0B	1.2B	1.8B	1.7B	1.6B	1.4B	1.5B	825.0M
Financing Cash Flow	-618.0M	-565.0M	-54.6M	92.7M	174.0M	-142.0M	312.0M	-35.5M	-88.0M	-32.5M	-174.0M	464.0M	22.2M	-476.0M	-14.5M	-221.0M	31.5M	-130.0M	374.0M	248.0M
Net Change In Cash	-108.0M	94.2M	401.0M	34.0M	-65.3M	-112.0M	-150.0M	-157.0M	52.2M	-83.2M	-29.5M	334.0M	-11.0M	107.0M	-42.6M	14.8M	-96.4M	-286.0M	338.0M	-14.8M
Ending Cash Balance	595.0M	703.0M	609.0M	207.0M	173.0M	239.0M	339.0M	480.0M	636.0M	453.0M	536.0M	566.0M	232.0M	242.0M	135.0M	178.0M	163.0M	259.0M	545.0M	--
Capex	77.7M	133.0M	202.0M	371.0M	459.0M	295.0M	220.0M	121.0M	79.7M	45.3M	16.8M	310.0M	75.6M	62.8M	148.0M	202.0M	358.0M	225.0M	70.9M	156.0M